No. 8,Longyang Avenue
Jointown, a large-scale enterprise group involving in the main businesses of FDF, TCM and herbs, medical devices and consumer goods, providing pharmaceutical facilities, medical institute, whole sellers and retail pharmacies with pharmaceutical distribution and logistics services, and offering terminal customers and consumers with E-commerce and health management service through the Internet. Applied itself to the medical and massive health industry, Jointown has become one of the few enterprises that own nationwide network in field of pharmaceutical business in China. Since the successful listing on Shanghai Stock Exchange (Stock abbreviation: Jointown, Stock code: 600998) on November 2nd, 2010, Jointown has developed itself as the forth of Chinese pharmaceutical business enterprises for years and takes the lead in race among private pharmaceutical business enterprises in China, ranking the list of 100th of Fortune 500 (China version) in 2020.
Jointown was founded in March,1999 and its headquarters locates in Wuhan, Hubei province. As of June 30, 2020, its registered capital reaches 1.878 billion RMB and total assets reaches 72.854 billion RMB. The annual revenue and net profit hit 51.349 billion RMB and 1.602 billion RMB respectively and 6.03% and 110.22% higher over the same period of last year. The net profit attributable to shareholders of the listed company after deducting non-recurring profits and losses is 959 million RMB, a sharp increase of 55.44% over the same period of last year. The annual revenue and net profit of 2019 is 99.497 billion RMB and 1.781 billion RMB respectively and 14.19% and 28.96% higher over the same period of last year. Jointown has more than 25,000 employees and 1,074 direct and franchised retail chain pharmacies.
Jointown adopts SWANS strategic managing system to implement its business planning that led by the overall strategy of “Make professional pharmaceutical distribution, do excellent product marketing, provide innovative Internet service and solidify high-quality development”, to seize development opportunity and tactically strategize the “456” business mode, namely 4 core businesses: medical treatment, sole agency, terminal marketing, distribution;5 strategic businesses: medical devices, TCM, Health 998, biological products and third party logistics;6 other businesses: APIs, consumer goods, medical information, fund investment, medical and health care integration and medical industry, as well as the strategic development thinking of “solidify core businesses, expand strategic businesses and optimize other businesses”.
Count on nationwide marketing network and rich upstream and downstream resources, Jointown successively established 31 provincial subsidiaries (large pharmaceutical logistics center) and 104 prefecture-level molecular companies (regional distribution center)in Hubei, Beijing, Shanghai, Guangdong, Henan, Xinjiang and other regional central cities and provincial cities, that weaving a marketing network covering more than 95% of the administrative areas all over the country. The company operates more than 410,000 SKUs and has become one of the enterprises that own most complete product portfolio within the industry. More than 10,000 upstream suppliers and about 200,000 downstream customers have obtained the national or regional exclusive distribution or general agent qualification for nearly thousands of medicines in China, which ensures the diversified needs of customers and satisfies the "one-stop" purchasing experience.
Jointown has 10 million pieces logistics storage capacity, its delivery efficiency reaches 10,000 rows/hour and delivery accuracy rate reaches 99.99%, and it owns more than 1,700 self-distributed vehicles. Jointown uphold the concept of "Technology makes services more excellence" and is committed to the development and application of modern logistics and information technology. Through independent designing, planning, system integration, Jointown has completed the construction of 135 modern pharmaceutical logistics centers and widely applied the Logistics Management Information System (LMIS), Warehouse Control System (WCS), Transportation Management System (TMS), “Joint Cloud” platform, third party logistics platform and electronic drug supervision code acquisition system with independent intellectual property rights, it also obtained related 313 computer software copyright. It is a pharmaceutical distribution enterprise with the ability to independently integrate logistics planning, logistics implementation and system integration, and has been awarded the honorary title of "Leading Enterprise of Chinas Logistics Reform and Opening up for 30 years".
Jointown strives to foster the FBBC business mode, integrate B2Band B2C exchange platform, expand B2C and O2O business and improve the intelligent health service platform. Relying on artificial intelligence technology, Jointown imports resources such as hospitals, Internet hospitals and telemedicine to build up an intelligent medical and pharmaceutical service platform that provides intelligent services for consumers and medical institutions and introduces prescriptions for pharmacies that applied the platform, which brings more business opportunities to the contracted pharmacies and clinics. Through the seamless integration of big data and business, the three platforms obtain more market product information, which not only brings impetus to the business growth of suppliers and the pharmacies in the market, but also promotes the business growth and platform transformation, enabling Jointown do more accurate and stable business in the pharmaceutical market.
Jointown bend itself to pioneer inbuilding up the TCM brand “JiuXin” that focuses on “stress brand, product and marketing & value foundation, talent and benefit” to drive the coordinated development of 5 sections of TCM whole industry chain.
Jointown continuously implements the medical equipment “KENIZI” strategy and accelerates the establishment of supply chain and operation mode concerning specialty products to realize its rapid growth. Jointown takes use of OEM and self-produced “METIKO” to build up self-owned brand for household-care and daily consumable products.
Jointown has established quality management network and strict medicine quality control system. A team of 600professionals expertized in strict quality control according to the requirements of GSP and relevant national standards, which guarantees the companys sustainable business development. At present, the company and 165 subordinate wholesale enterprises possess valid license for pharmaceutical trading. The company has formulated sound quality management system and standard operating procedures for each procedure of stocking, selling and storing. It also combined with advanced information technology to strict six phases of quality management. According to the new requirements of the new GSP, the company carries out detailed inventory management to create a whole-process cold chain distribution system.
Jointown has established a centralized group management and control system, set up a business information system and a sound communication mechanism to ensure the rapid implementation of various works. The company has strong competence of control and allocation in resources of labor, finance and materials, which can effectively reduce customer transaction costs, improve service quality and customer satisfaction and better serve upstream and downstream customers to further enhance company competitiveness.
Jointown advocates the “family culture” as the core of original enterprise culture system. The company is the home of employees, and thus the company undertaking is the cause of every employee. The development of the company is closely related to the future of every employee. Every employee, in whatever position, have the strong sense of responsibility, always be prepared for crisis, execute without compromise, maintain a positive attitude and keep team cohesiveness to jointly contribute to the company and together share the development results.
Jointown regards fulfilling social responsibility as an important approach to return to the society. The company proactively gives back to the society that has been widely recognized by the society. Jointown was awarded lots of honorable titles, such as “National 5A Logistics Enterprise”, “Most Influential Private Enterprise of Hubei Province”, “China Trustworthy Enterprise”, “China Excellent Enterprise with Social Responsibility”, “Top 100 Enterprise of Hubei Province”, “Top 100 China Private Service Enterprise” and “Top 500 Enterprise of China” in recent years.
With the company mission of "Protecting peoples health, providing customers benefits and creating a win-win cooperation platform", Jointown has expanded and improved the distribution of pharmaceutical marketing network, and strived to be the most professional big health service platform in China that orient customer as the center, performance as the guidance, culture as the drive and quality as the life being.